Press Releases
Search
-
20 Oct 2005
Nine-Month Sales Up 5%
Marcy l'Etoile, France - October 20, 2005. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its nine-month 2005 sales.
-
13 Oct 2005
bioMérieux and ExonHit Therapeutics Extend their Strategic Collaboration
Marcy l'Etoile and Paris, France - October 13, 2005. bioMérieux and ExonHit announced today that they signed an agreement to extend their collaboration for six years for the discovery and development ...
-
01 Oct 2005
bioMérieux Announces 23% Increase in First-Half 2004 Operating Income and Net Income
Marcy l'Etoile, France - October 1st, 2004. bioMérieux, a global leader in the field of in vitro diagnostics, today announces a significant increase in its financial results for the six months ended J...
-
27 Jul 2005
DiagnoSwiss and bioMérieux announce that they have signed an exclusive license agreement for the development and use of DiagnoSwiss electrochemical microchips in human in vitro diagnostics
Marcy l’Etoile - July 27, 2005. Monthey (Switzerland) – Marcy l’Etoile (France), July 27, 2005 – bioMérieux and DiagnoSwiss announced today that DiagnoSwiss has granted bioMérieux with an exclusive wo...
-
20 Jul 2005
First half 2005 sales up 4.0%, second quarter up 7.8%, excluding the currency effect
Marcy l'Etoile, France - 20 July 2005. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its first-half 2005 sales.
-
05 Jul 2005
Hepanostika® HBsAg Ultra – New “ultra”-sensitive test for Hepatitis B infection from bioMérieux
Marcy l’Etoile, France - July 5th, 2005. bioMérieux, a world leader in the field of in vitro diagnostics, announces the launch of its new microelisa assay for the detection of hepatitis B surface anti...
-
23 Jun 2005
Hospices Civils de Lyon and bioMérieux inaugurate a joint immunogenomics and inflammation unit
Lyon, France - June 23, 2005. Hospices Civils de Lyon (HCL) and bioMérieux will inaugurate today the “HCL-bioMérieux” joint unit dedicated to research in immunogenomics and inflammation. The unit is h...
-
07 Jun 2005
NucliSens® easyMAG™ – new innovation from bioMérieux for nucleic acid extraction
Marcy l'Etoile - France - June 7th, 2005. A world leader in the field of in vitro diagnostics, bioMérieux announces the launch of its new automated sample preparation platform for the extraction of nu...
-
25 May 2005
25/05/2005 - MRSA ID - bioMérieux’s latest contribution to the fight against nosocomial infections
Marcy l’Etoile, France - May 25th, 2005. A world leader in the field of in vitro diagnostics, bioMérieux SA announces the launch of a new product for rapid, reliable identification of Methicillin-Resi...
-
23 May 2005
Prospectus about a share buy back program to be submitted at the shareholders' meeting to be held on June 9, 2005
Marcy l'Etoile, France - May 23, 2005.
-
29 Apr 2005
Roche Diagnostics and bioMérieux announce that Roche has granted non exclusive rights for cardiac markers NT-proBNP to bioMérieux
Marcy l’Etoile, France - April 29, 2005. Roche Diagnostics and bioMérieux announced today, that bioMérieux has been granted a nonexclusive license agreement under the patent rights of Roche Diagnostic...
-
20 Apr 2005
First-Quarter 2005 Sales Stable at Constant Exchange Rates
Marcy l'Etoile, France - April 20, 2005. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its first-quarter 2005 sales.
-
15 Apr 2005
bioMérieux invests in the future of emergency diagnostics
Marcy l’Etoile, France - April 15, 2005. A world leader in the field of in vitro diagnostics, with over 40 years experience in infectious diseases, bioMérieux SA recently confirmed its commitment to t...
-
05 Apr 2005
Affymetrix and bioMérieux Extend Their Agreement on GeneChip® Technology to Breast Cancer Diagnostics
Santa Clara, Calif., US and Marcy l’Etoile, France - April 5, 2005. The agreement includes an option for bioMérieux to use Affymetrix GeneChip® technology in other cancer areas. Affymetrix Inc. (Nasda...
-
25 Mar 2005
NucliSens® miniMAG™, bioMérieux’s next generation nucleic acid extraction platform is now available as CE-IVD approved platform
Marcy l'Etoile, France - March 25, 2005. bioMérieux announces the introduction of the NucliSens miniMAG and NucliSens Magnetic Extraction Reagents as CE-IVD marked products. A major actor in the field...